HEALWELL AI Posts Record Revenue and Turns Adjusted EBITDA Positive as It Becomes Pure-Play AI Software Firm
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HEALWELL AI ( (TSE:AIDX) ) just unveiled an update.
HEALWELL AI reported record fiscal 2025 revenue from continuing operations of about $103.8 million, up 427% year over year, and delivered its first full year of positive adjusted EBITDA of $2.3 million, despite an IFRS net loss of $39.1 million. Management highlighted a $16.5 million swing in adjusted EBITDA, three consecutive quarters of positive adjusted EBITDA, and clear operating leverage as Orion Health integration synergies and enterprise AI deployments scale.
During the year, HEALWELL completed strategic divestments to become a pure-play AI and software business, generating roughly $9.7 million in cash proceeds and ending 2025 with $18.6 million in cash plus additional strategic investments under review. The company is pushing from proof-of-concept to scaled deployment, citing a government AI health system contract in the Middle East, a multi-million-dollar U.S. health information exchange deal, and expanding enterprise AI deployments in Canada as evidence of growing adoption within core clinical infrastructure.
Leadership emphasized that HEALWELL now operates in two high-margin, scalable segments—AI and Data Science, and Healthcare Software—supported by over 70 enterprise customers and 47 peer-reviewed publications validating its technology. The strategic repositioning and strengthening balance sheet are intended to solidify the company’s competitive moat and support its goal of translating platform economics into sustained profitability as it scales globally.
The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$3.10 price target. To see the full list of analyst forecasts on HEALWELL AI stock, see the TSE:AIDX Stock Forecast page.
Spark’s Take on AIDX Stock
According to Spark, TipRanks’ AI Analyst, AIDX is a Neutral.
The score is held back primarily by weak financial performance (large losses and negative free cash flow) and bearish technicals (price below key moving averages with negative MACD). The latest earnings call provides a meaningful offset with strong integration-driven revenue growth and positive adjusted EBITDA, but valuation remains constrained by losses and there is no dividend support.
To see Spark’s full report on AIDX stock, click here.
More about HEALWELL AI
HEALWELL AI Inc. is a healthcare artificial intelligence company focused on preventative care, delivering AI and data science solutions and healthcare software through a global enterprise distribution network. The company’s platform, underpinned by its DARWEN AI engine, Orion Health’s reach across 11 countries, and the WELLTRUST consent-based data network, targets governments and large health systems worldwide.
Average Trading Volume: 563,023
Technical Sentiment Signal: Sell
Current Market Cap: C$302.2M
Find detailed analytics on AIDX stock on TipRanks’ Stock Analysis page.
